Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02934321 · ClinicalTrials.gov registry record · NA
Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage
A NA study of Satiety in Healthy Volunteers, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02934321 is a NA study of Satiety in Healthy Volunteers that has completed, run by University of Florida. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02934321, a NA study of Satiety in Healthy Volunteers, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Erythritol is a low calorie sugar substitute that is being increasingly used to sweeten beverages and other food items. Greater amounts of erythritol are required to reach the sweetness level of a common soft drink as compared to aspartame, resulting in higher osmolarity for the erythritol sweetened beverage. Since associations have been noted between osmolarity and satiety, investigators propose that an erythritol sweetened beverage may enhance satiety more than a beverage sweetened with aspartame.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Erythritol
- DIETARY_SUPPLEMENT Aspartame
Study Locations (1)
Florida
- University of Florida Clinical Research Center - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2019-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02934321
The ClinicalTrials.gov registry entry for NCT02934321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Satiety in Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which Erythritol is the first listed.
NCT02934321 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02934321 about?
NCT02934321 is a clinical study titled "Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage". Erythritol is a low calorie sugar substitute that is being increasingly used to sweeten beverages and other food items. Greater amounts of erythritol are required to reach the sweetness level of a common soft drink as compared to aspartame, resulting in higher osmolarity for the erythritol sweetened...
What is the current status of trial NCT02934321?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-09-18. Estimated completion is 2019-08-23.
What conditions does trial NCT02934321 study?
This clinical trial studies the following conditions: Satiety in Healthy Volunteers.
What interventions are being tested in trial NCT02934321?
The interventions under investigation include: Erythritol (DIETARY_SUPPLEMENT), Aspartame (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02934321?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02934321 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.